Safety and Efficacy of Sevelamer in the Treatment of Uncontrolled Hyperphosphataemia of Haemodialysis Patients

Publisher： Karger

E-ISSN： 1660-2110|97|1|c17-c22

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.97, Iss.1, 2004-11, pp. : c17-c22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy of sofosbuvir‐based treatment of acute hepatitis C in end‐stage renal disease patients undergoing haemodialysis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 526-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Intravenous Iron Therapy for HCV-Positive Haemodialysis Patients

By  

Nephron Clin Pract, Vol. 100, Iss. 3, 2005-04 ,pp. : c78-c85

Karger

Access to resources Recommend Favorite

Patients’ experiences of safety during haemodialysis treatment – a qualitative study

By  

JOURNAL OF ADVANCED NURSING, Vol. 71, Iss. 10, 2015-10 ,pp. : 2374-2383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Sevelamer on the Progression of Vascular Calcification in Patients on Chronic Haemodialysis

By  

Nephron Clin Pract, Vol. 108, Iss. 4, 2008-04 ,pp. : c278-c283

Karger

Access to resources Recommend Favorite

Epoetin theta: efficacy and safety of IV administration in anaemic haemodialysis patients in the maintenance phase in comparison to epoetin beta

By Gertz B.   Kohler E.   Kes P.   Essaian A.   Bias P.   Buchner A.   Elsässer R.  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2393-2402

Informa Healthcare

Access to resources Recommend Favorite